Preview Mode Links will not work in preview mode

Dec 28, 2022

Featuring perspectives from Drs Alexey Danilov, Matthew Davids, Lindsey Roeker, Philip Thompson and Prof Dr Arnon Kater, including the following topics:

  • Front-Line Treatment of Chronic Lymphocytic Leukemia (CLL)  
    • Introduction (0:00)
    • Cases: A man in his early 90s with Rai Stage 0 CLL who underwent surveillance x 5...

Dec 22, 2022

Featuring perspectives from Drs Erika Hamilton, Sara Hurvitz, Ian Krop, Shanu Modi and Sara Tolaney, including the following topics:

  • Optimizing the Management of Localized HER2-Positive Breast Cancer
    • Introduction (0:00)
    • Case: A woman in her mid 60s with pulmonary hypertension and triple-positive, node-positive...

Dec 21, 2022

Featuring a slide presentation and related discussion from Dr Thomas Herzog, including the following topics:

  • Keys to evaluating genetics in patients with ovarian cancer (0:00)
  • Clinical trials evaluating PARP inhibitor maintenance therapy for patients with newly diagnosed ovarian cancer responding to platinum-based...

Dec 21, 2022

Featuring perspectives from Dr Thomas Herzog, including the following topics:

  • Impact of PARP inhibitors (PARPi) on the care of patients with ovarian cancer (0:00)
  • Clarifying the recent withdrawal of PARPi for treatment of recurrent or refractory ovarian cancer (4:13)
  • Sequential use of PARPi for patients with advanced...

Dec 16, 2022

Emerging Role of Antibody‑Drug Conjugates in the Management of Non‑Small Cell Lung Cancer — Faculty Presentation 2: TROP2 and Other Investigational Targets for ADCs in Advanced NSCLC — Dr Alexander Spira

CME information and select publications